María J. Calasanz

TP53 is frequently altered by methylation, mutation, and/or deletion in acute lymphoblastic leukaemia

M. Calasanz, X. Agirre, M. García-Delgado, 2003, Molecular carcinogenesis.

p53 Aberrations do not predict individual response to fludarabine in patients with B‐cell chronic lymphocytic leukaemia in advanced stages Rai III/IV

M. Odero, M. Calasanz, X. Agirre, 2005, British journal of haematology.

Molecular heterogeneity in AML/MDS patients with 3q21q26 rearrangements

M. Odero, M. Calasanz, X. Agirre, 2004, Genes, chromosomes & cancer.

t(10;16)(q22;p13) and MORF‐CREBBP fusion is a recurrent event in acute myeloid leukemia

M. Odero, M. Calasanz, F. J. Novo, 2003, Genes, chromosomes & cancer.